These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25157214)

  • 41. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
    Br J Anaesth; 2010 Nov; 105(5):568-75. PubMed ID: 20937718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
    Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
    Cammu G; Coart D; De Graeve K; Beelen R
    Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
    Zwiers A; van den Heuvel M; Smeets J; Rutherford S
    Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate].
    Sakurai Y; Uchida M; Aiba J; Mimura F; Yamaguchi M; Kakumoto M
    Masui; 2014 Mar; 63(3):315-9. PubMed ID: 24724442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
    Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
    Suzuki T; Kitajima O; Ueda K; Kondo Y; Kato J; Ogawa S
    Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sugammadex for reversal of moderate-to-deep rocuronium block in a clinical setting: A retrospective report of 10 dogs.
    Martin-Flores M
    Vet Anaesth Analg; 2024 Jan; 51(1):60-63. PubMed ID: 38072747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recovery time after sugammadex reversal of rocuronium-induced muscle relaxation for electroconvulsive therapy is independent of cardiac output in both young and elderly patients.
    Kadoi Y; Nishida A; Saito S
    J ECT; 2013 Mar; 29(1):33-6. PubMed ID: 23052151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
    Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
    Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective observational study of the effects of residual neuromuscular blockade and sugammadex on motor-evoked potential monitoring during spine surgery in Japan.
    Hayashi H; Yamada M; Okuyama K; Takatani T; Shigematsu H; Tanaka Y; Kawaguchi M
    Medicine (Baltimore); 2022 Sep; 101(39):e30841. PubMed ID: 36181124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.